Delivery Order SPE2DB24D9113-SPE2DB25FEQCX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, and represents no set-aside designation. The award falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $61,538.77 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for MACI 3cm x 5cm implant sheets. The contract, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $61,902.91 for MACI 3cm x 5cm implant sheets. The contract, issued on June 26, 2025, with an ultimate completion date of July 18, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc. for MACI 3cm x 5cm implant sheets. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The delivery order was issued on July 18, 2025, with an ultimate completion date of August 8, 2025, and no set-aside designation was used in this procurement...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The contract is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA's SPE2DB...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The contract represents a discrete order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc. for MACI 3cm x 5cm implant sheets. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The contract carries no set-aside designation and has an ultimate completion date of September 24, 2025. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The contract is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and was awarded on August 7, 2025. This award utilizes no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market...
- SPE2DB24D9113Indefinite Delivery Contract
- SPE2DB24D9113-SPE2DB25FEQCXDelivery Order
The Defense Logistics Agency awarded a $61,902.91 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 26, 2025, for MACI 3cm x 5cm implant sheets, with an ultimate completion date of September 17, 2025. This delivery order was issued without a set-aside designation and represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The Park Ridge, Illinois-based woman-owned small business specializes in pharmaceutical product distribution to federal healthcare facilities, with particular expertise in supplying medical devices and specialty pharmaceuticals to military health systems. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its SPE2DB program contract with DLA, enabling the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical inventory needs across Department of Defense medical facilities worldwide. The company's contract portfolio demonstrates consistent success in competitive federal procurement, covering an extensive range of products from branded and generic prescription medications to biologics, vaccines, and specialized medical consumables. This particular delivery order for MACI implant sheets aligns with the company's established track record of supplying advanced medical devices and pharmaceutical products that support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.9k | 8/26/25 |